BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24697209)

  • 1. Novel approaches to the development of anti-sepsis drugs.
    Lehmann C; Sharawi N; Al-Banna N; Corbett N; Kuethe JW; Caldwell CC
    Expert Opin Drug Discov; 2014 May; 9(5):523-31. PubMed ID: 24697209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and toxicological considerations for sepsis drug treatments.
    Campbell SC; Spigarelli MG; Courter J; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):79-89. PubMed ID: 22998292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-modulating interventions in critically ill septic patients: pharmacological options.
    Toft P; Tønnesen E
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):491-501. PubMed ID: 22114858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
    Krawczyk-Michalak K; Glapiński A; Brzezińska-Błaszczyk E
    Anestezjol Intens Ter; 2008; 40(4):253-59. PubMed ID: 19517667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel RNA interference-based therapies for sepsis.
    Kosovrasti VY; Lukashev D; Nechev LV; Amiji MM
    Expert Opin Biol Ther; 2014 Apr; 14(4):419-35. PubMed ID: 24397825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
    Bae JS
    Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of proteomics in understanding biological mechanisms of sepsis.
    Cao Z; Robinson RA
    Proteomics Clin Appl; 2014 Feb; 8(1-2):35-52. PubMed ID: 24339042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing injection].
    Gao YL; Chai YF; Yao YM
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):162-5. PubMed ID: 23985206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis.
    Da J; Chen L; Hedenstierna G
    Crit Care Med; 2007 Jan; 35(1):26-32. PubMed ID: 17095945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of sepsis.
    van der Poll T
    Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring immunomodulation in patients with sepsis.
    Kyriazopoulou E; Giamarellos-Bourboulis EJ
    Expert Rev Mol Diagn; 2021 Jan; 21(1):17-29. PubMed ID: 33183116
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinically-oriented therapies in sepsis: a review.
    Dubois MJ; Vincent JL
    J Endotoxin Res; 2000; 6(6):463-9. PubMed ID: 11521072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.
    Lafreniere JD; Lehmann C
    Metabolites; 2017 Nov; 7(4):. PubMed ID: 29104224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation.
    Zhao Y; Pu M; Zhang J; Wang Y; Yan X; Yu L; He Z
    Nanoscale; 2021 Jun; 13(24):10726-10747. PubMed ID: 34165483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic, immunologic, and clinical aspects of sepsis - update 2016.
    Uhle F; Chousterman BG; Grützmann R; Brenner T; Weber GF
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):917-27. PubMed ID: 27530423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antiplatelet agents in sepsis: a glimpse into the future.
    Akinosoglou K; Alexopoulos D
    Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitions and pathophysiology of sepsis.
    Sagy M; Al-Qaqaa Y; Kim P
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(10):260-3. PubMed ID: 24295606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.